Literature DB >> 28442546

Modeled structural basis for the recognition of α2-3-sialyllactose by soluble Klotho.

Jon D Wright1, Sung-Wan An2, Jian Xie2, Joonho Yoon2, Nicole Nischan3, Jennifer J Kohler3, Noelynn Oliver4, Carmay Lim5,6, Chou-Long Huang7.   

Abstract

Soluble Klotho (sKlotho) is the shed ectodomain of antiaging membrane Klotho that contains 2 extracellular domains KL1 and KL2, each of which shares sequence homology to glycosyl hydrolases. sKlotho elicits pleiotropic cellular responses with a poorly understood mechanism of action. Notably, in injury settings, sKlotho confers cardiac and renal protection by down-regulating calcium-permeable transient receptor potential canonical type isoform 6 (TRPC6) channels in cardiomyocytes and glomerular podocytes. Inhibition of PI3K-dependent exocytosis of TRPC6 is thought to be the underlying mechanism, and recent studies showed that sKlotho interacts with α2-3-sialyllactose-containing gangliosides enriched in lipid rafts to inhibit raft-dependent PI3K signaling. However, the structural basis for binding and recognition of α2-3-sialyllactose by sKlotho is unknown. Using homology modeling followed by docking, we identified key protein residues in the KL1 domain that are likely involved in binding sialyllactose. Functional experiments based on the ability of Klotho to down-regulate TRPC6 channel activity confirm the importance of these residues. Furthermore, KL1 domain binds α2-3-sialyllactose, down-regulates TRPC6 channels, and exerts protection against stress-induced cardiac hypertrophy in mice. Our results support the notion that sialogangliosides and lipid rafts are membrane receptors for sKlotho and that the KL1 domain is sufficient for the tested biologic activities. These findings can help guide the design of a simpler Klotho mimetic.-Wright, J. D., An, S.-W., Xie, J., Yoon, J., Nischan, N., Kohler, J. J., Oliver, N., Lim, C., Huang, C.-L. Modeled structural basis for the recognition of α2-3-sialyllactose by soluble Klotho. © FASEB.

Entities:  

Keywords:  KL1 domain; PI3K; TRPC6

Mesh:

Substances:

Year:  2017        PMID: 28442546      PMCID: PMC5503716          DOI: 10.1096/fj.201700043R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  43 in total

1.  Structural insights into the catalytic mechanism of Trypanosoma cruzi trans-sialidase.

Authors:  María Fernanda Amaya; Andrew G Watts; Iben Damager; Annemarie Wehenkel; Tong Nguyen; Alejandro Buschiazzo; Gastón Paris; A Carlos Frasch; Stephen G Withers; Pedro M Alzari
Journal:  Structure       Date:  2004-05       Impact factor: 5.006

2.  Soluble klotho binds monosialoganglioside to regulate membrane microdomains and growth factor signaling.

Authors:  George Dalton; Sung-Wan An; Saif I Al-Juboori; Nicole Nischan; Joonho Yoon; Evgenia Dobrinskikh; Donald W Hilgemann; Jian Xie; Kate Luby-Phelps; Jennifer J Kohler; Lutz Birnbaumer; Chou-Long Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-09       Impact factor: 11.205

3.  Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23.

Authors: 
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

4.  Klotho suppresses RIG-I-mediated senescence-associated inflammation.

Authors:  Feng Liu; Su Wu; Hongwei Ren; Jun Gu
Journal:  Nat Cell Biol       Date:  2011-02-20       Impact factor: 28.824

5.  Structural studies of the parainfluenza virus 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose.

Authors:  Ping Yuan; Thomas B Thompson; Beth A Wurzburg; Reay G Paterson; Robert A Lamb; Theodore S Jardetzky
Journal:  Structure       Date:  2005-05       Impact factor: 5.006

6.  High-resolution structures of Neotermes koshunensis β-glucosidase mutants provide insights into the catalytic mechanism and the synthesis of glucoconjugates.

Authors:  Wen-Yih Jeng; Nai-Chen Wang; Cheng-Tse Lin; Wei-Jung Chang; Chia-I Liu; Andrew H-J Wang
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2012-06-19

7.  Klotho-related protein is a novel cytosolic neutral beta-glycosylceramidase.

Authors:  Yasuhiro Hayashi; Nozomu Okino; Yoshimitsu Kakuta; Toshihide Shikanai; Motohiro Tani; Hisashi Narimatsu; Makoto Ito
Journal:  J Biol Chem       Date:  2007-06-26       Impact factor: 5.157

8.  Association of klotho gene polymorphism with bone density and spondylosis of the lumbar spine in postmenopausal women.

Authors:  N Ogata; Y Matsumura; M Shiraki; K Kawano; Y Koshizuka; T Hosoi; K Nakamura; M Kuro-O; H Kawaguchi
Journal:  Bone       Date:  2002-07       Impact factor: 4.398

9.  Klotho is a novel beta-glucuronidase capable of hydrolyzing steroid beta-glucuronides.

Authors:  Osamu Tohyama; Akihiro Imura; Akiko Iwano; Jean-Noël Freund; Bernard Henrissat; Toshihiko Fujimori; Yo-ichi Nabeshima
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

10.  Identification of a novel mouse membrane-bound family 1 glycosidase-like protein, which carries an atypical active site structure.

Authors:  Shinji Ito; Toshihiko Fujimori; Yoshihide Hayashizaki; Yo-ichi Nabeshima
Journal:  Biochim Biophys Acta       Date:  2002-07-19
View more
  15 in total

1.  Untangling the thread of life spun by αKlotho.

Authors:  Edward R Smith
Journal:  J Mol Med (Berl)       Date:  2018-07-27       Impact factor: 4.599

Review 2.  αKlotho-FGF23 interactions and their role in kidney disease: a molecular insight.

Authors:  Edward R Smith; Stephen G Holt; Tim D Hewitson
Journal:  Cell Mol Life Sci       Date:  2019-07-26       Impact factor: 9.261

3.  A Controlled Increase in Dietary Phosphate Elevates BP in Healthy Human Subjects.

Authors:  Jaber Mohammad; Roberto Scanni; Lukas Bestmann; Henry N Hulter; Reto Krapf
Journal:  J Am Soc Nephrol       Date:  2018-07-18       Impact factor: 10.121

4.  FGF23 expression is stimulated in transgenic α-Klotho longevity mouse model.

Authors:  Zhousheng Xiao; Gwendalyn King; Salvatore Mancarella; Undral Munkhsaikhan; Li Cao; Chun Cai; Leigh Darryl Quarles
Journal:  JCI Insight       Date:  2019-12-05

5.  Soluble klotho regulates TRPC6 calcium signaling via lipid rafts, independent of the FGFR-FGF23 pathway.

Authors:  Jon D Wright; Sung-Wan An; Jian Xie; Carmay Lim; Chou-Long Huang
Journal:  FASEB J       Date:  2019-05-07       Impact factor: 5.191

Review 6.  The Klotho proteins in health and disease.

Authors:  Makoto Kuro-O
Journal:  Nat Rev Nephrol       Date:  2019-01       Impact factor: 28.314

Review 7.  New Insights into the Mechanism of Action of Soluble Klotho.

Authors:  George D Dalton; Jian Xie; Sung-Wan An; Chou-Long Huang
Journal:  Front Endocrinol (Lausanne)       Date:  2017-11-17       Impact factor: 5.555

8.  Klotho is upregulated in human cardiomyopathy independently of circulating Klotho levels.

Authors:  G Poelzl; S K Ghadge; M Messner; B Haubner; Ph Wuertinger; A Griesmacher; J Doerler; C Ensinger; H Ulmer; M M Zaruba
Journal:  Sci Rep       Date:  2018-05-30       Impact factor: 4.379

Review 9.  The role of klotho in chronic kidney disease.

Authors:  Di Zou; Wen Wu; Yan He; Sichao Ma; Ji Gao
Journal:  BMC Nephrol       Date:  2018-10-22       Impact factor: 2.388

Review 10.  FGF23 Actions on Target Tissues-With and Without Klotho.

Authors:  Beatrice Richter; Christian Faul
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-02       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.